This substantiates that when IL-17RA signaling is missing uncontrolled production of IL-1 is at least partially responsible for the increased damage and enhanced neutrophil response, and that α-IL-1R is a viable treatment option to explore in OM. The gene discussed is IL17RA; the disease is ocular melanoma.